InventisBio Co., Limited (SHA:688382)
China flag China · Delayed Price · Currency is CNY
11.71
-0.68 (-5.49%)
At close: Nov 17, 2026

InventisBio Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
816.371,3811,5861,9192,235724.25
Trading Asset Securities
417.96153.68101.3---
Cash & Short-Term Investments
1,2341,5351,6871,9192,235724.25
Cash Growth
-19.57%-9.04%-12.10%-14.13%208.62%-29.90%
Accounts Receivable
81.4284.67165.34176.57--
Other Receivables
5.084.465.936.653.984.25
Receivables
86.589.12171.28183.213.984.25
Other Current Assets
44.2327.5211.6920.4626.2812.95
Total Current Assets
1,3651,6511,8702,1232,265741.45
Property, Plant & Equipment
28.0830.0744.8230.3847.1444.02
Other Intangible Assets
0.71.430.590.921.250.11
Long-Term Deferred Tax Assets
2.413.193.442.96.22-
Long-Term Deferred Charges
8.3710.01-1.054.48.42
Other Long-Term Assets
21.687.921.863.923.356.02
Total Assets
1,4271,7041,9212,1622,348800.03

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
77.65115.4859.9672.5262.2564.22
Accrued Expenses
11.2924.8221.6228.8636.1925.71
Current Portion of Leases
6.127.157.79912.078.71
Current Unearned Revenue
---47.17--
Other Current Liabilities
3.031.450.610.720.510.22
Total Current Liabilities
98.09148.989.98158.27111.0298.85
Long-Term Leases
11.3814.9216.132.6115.2714.94
Long-Term Unearned Revenue
0.480.480.480.880.41.2
Long-Term Deferred Tax Liabilities
2.593.433.442.96.22-
Total Liabilities
112.54167.73110.03164.67132.9115

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
579.61578.35576.75575575460
Additional Paid-In Capital
3,8533,8323,7913,7383,6711,773
Retained Earnings
-3,106-2,862-2,545-2,305-2,021-1,537
Comprehensive Income & Other
-11.82-12.41-11.9-10.74-10.4-10.79
Shareholders' Equity
1,3151,5361,8111,9982,215685.03
Total Liabilities & Equity
1,4271,7041,9212,1622,348800.03

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
17.4922.0723.9211.6227.3423.66
Net Cash (Debt)
1,2171,5131,6631,9082,208700.6
Net Cash Growth
-19.59%-9.06%-12.82%-13.59%215.14%-32.20%
Net Cash Per Share
2.132.632.913.324.341.53
Filing Date Shares Outstanding
579.61578.35576.75575575460
Total Common Shares Outstanding
579.61578.35576.75575575460
Working Capital
1,2671,5021,7801,9652,154642.6
Book Value Per Share
2.272.663.143.473.851.49
Tangible Book Value
1,3141,5351,8101,9972,214684.92
Tangible Book Value Per Share
2.272.653.143.473.851.49
Machinery
-32.8632.5532.0427.0723.91
Construction In Progress
--6.470.52.581.87